NCT01229163

Automated Prize-based Contingency Management to Increase Counseling Attendance in Opiate-Replacement-Therapy Patients

Completed EARLY_PHASE1 Last updated 5 April 2018

What this trial tests

EARLY_PHASE1 trial testing Automated Contingency Management (ACM) software in Opiate-Replacement Therapy in 25 participants. Completed in 19 April 2012.

Timeline

3 October 2010

Primary endpoint
9 April 2012

19 April 2012

Quick facts

Lead sponsor	National Institute on Drug Abuse (NIDA)
Phase	EARLY_PHASE1
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	single group
Masking	none
Primary purpose	other
Enrollment	25
Start date	3 October 2010
Primary completion	9 April 2012
Estimated completion	19 April 2012
Sites	1 location across United States

Drugs / interventions tested

• Automated Contingency Management (ACM) software

Conditions studied

• Opiate-Replacement Therapy — all drugs for Opiate-Replacement Therapy →

Sponsor

National Institute on Drug Abuse (NIDA)

Who can join

Adults 18 to 65, any sex, with Opiate-Replacement Therapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background:

\- Treatment outcomes for substance abuse are improved by regular attendance at counseling sessions, and attending at counseling sessions can be futher improved by prize-based incentives. However, a system of prize-based incentives can be difficult to administer without computerization for accurate recordkeeping and rapid calculation of earnings. NIDA researchers have developed the eXtensible Platform for Motivational Incentives (XPMI), a computer program that for reinforcement of weekly counseling attendance. Users are eligible to win prizes through automated draws. The researchers are interested in testing the effectiveness and ease of use of the XPMI software so it can ultimately be run by staff in community treatment programs.

Objectives:

* To test the XPMI program in a clinic setting, with emphasis on its functionality, usability, and acceptability for counselors.
* To test and validate XPMI s accuracy in calculating incentives to reinforce drug abstinence.

Eligibility:

\- Individuals at least 18 years of age who are participating in clinical trials for treatment of heroin dependence in an outpatient treatment-research program, and have at least 14 weeks remaining in the program.

Design:

* Participants will meet with their counselors as regularly scheduled. Twelve of the visits will count toward this study, with 2 extra weeks in case of counselor absence or clinic closure.
* Participants will receive an incentive in the form of a prize draw for arriving to counseling appointments on time, on the scheduled day. (Participants may reschedule one appointment per week without losing the chance for a prize draw.) For each consecutive appointment attended on time, participants will receive extra prize draws; attending three counseling appointments in a row can earn four bonus prize draws.
* To draw for prizes, participants will push a button on a computer. Each prize draw could result in a small prize worth $1 to $2, a large prize worth $20, a jumbo prize worth $100, or no prize at all. The average prize total per person is expected to be about $378.
* Participants will also be asked to fill out questionnaires about the computer program.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.